References

Aiken, J. (2001). “City Targets Illegal Prescription Drug Trade.” [Full Text]

Alliance of States With Prescription Monitoring Programs (1999). The Goals of Prescription Monitoring. Waltham, Mass.: Alliance of States With Prescription Monitoring Programs. [Full Text]

Clarke, R. (ed.) ( 1997). Situational Crime Prevention: Successful Case Studies (2nd ed.). Albany, N.Y.: Harrow and Heston.

Community Antidrug Coalitions of America (2001). Prescription Drug Abuse Prevention - Where Do We Go From Here? Alexandria, Va.: Community Antidrug Coalitions of America.

Cooper, J., D. Czechowicz, S. Molinari, and R. Petersen (eds.) (1993). Impact of Prescription Drug Control Systems on Medical Practice and Patient Care, NIDA Research Monograph 131. Rockville, Md.: National Institute on Drug Abuse. [Full Text]

Florida Department of Law Enforcement, Office of Statewide Intelligence (2001). Overview of Prescription Drug Abuse and the Oxycodone Problem in Florida. Tallahassee, Fla.: Florida Department of Law Enforcement. [Full Text]

Forgione, D., P. Neuenschwander, and T. Vermeer (2001). “Diversion of Prescription Drugs to the Black Market: What the States Are Doing to Curb the Tide.” Journal of Health Care Finance 27(4):65–78.

Fountain, J., P. Griffiths, M. Farrell, M. Gossop, and J. Strang (1997). “Diversion Tactics: How a Sample of Drug Misusers in Treatment Obtained Surplus Drugs to Sell on the Illicit Market.” International Journal of Drug Policy 9:159–167.

Goetz, K. (2001). “The OxyContin Pipeline: Multistate Network Keeps Appalachia Hooked, Cincinnati Part of ‘Near-Epidemic.’” Cincinnati Enquirer, February 25. [Full Text]

Joranson, D., G. Carrow, K. Ryan, L. Schaefer, A. Gilson, P. Good, J. Eadie, S. Peine, and J. Dahl (2002). “Pain Management and Prescription Monitoring.” Journal of Pain and Symptom Management 23(3):231–238.

Kalb, C. (2001). “Playing With Pain Killers” Newsweek, April 9.

Middleton, H. (2000). “Electronically Transmitted Prescriptions – A Good Idea?” ThePharmaceutical Journal 265(7107):172–176.

Mitka, M. (2000). “Abuse of Prescription Drugs: Is a Patient Ailing or Addicted?” JAMA: Journal of the American Medical Association 283(9):1126–1130.

National Association of Chain Drug Stores (2002). Community Pharmacy Projections.[Full Text]

National Association of State Controlled Substances Authorities and Alliance of States With Prescription Monitoring Programs (2002). Prescription Monitoring Program Model Act. [Full Text]

National Drug Intelligence Center (2001a). National Drug Threat Assessment 2002.[Full Text]

——— (2001b). “OxyContin Diversion and Abuse.” Information Bulletin (January):1–6. [Full Text]

——— (2000). National Drug Threat Assessment 2001: The Domestic Perspective. Johnstown, Pa.: U.S. Department of Justice, National Drug Intelligence Center. Also available at .[Full Text]

National Drug Strategy Network (1996). “Prescription Dru g Abuse Rivals Illicit Dru g Abuse, Some See Double Standard in Law Enforcement.” New Briefs – Dru g Use Trends.. [Full Text]

National Institute on Drug Abuse (2002). Prescription Drugs: Abuse and Addiction. Research Report Series. [Full Text]

Palm Beach County Sheriff’s Department (2003). [Full Text]

Payne, B., and D. Dabney (1997). “Prescription Fraud: Characteristics, Consequences, and Influences.” Journal of Drug Issues 27(4):807–820.

Purdue Pharma L.P. (2002). Purdue’s Antidiversion Efforts: Purdue Pharma’s 10-Point Plan to Reduce Prescription Drug Abuse and Diversion Without Compromising Patient Access to Proper Pain Control. Stamford, Conn.: Purdue Pharma L.P. [ Available through the Purdue Pharma L.P. Web Site]

Ramer, P. (2001). Overview of Prescription Drug Abuse and the Oxycodone Problem in Florida. Tallahassee, Fla.: Florida Department of Law Enforcement, Office of Statewide Intelligence. [Full Text]

Schober, B. (2001). “Prescription Drug Fraud Steadily Rising.”

Substance Abuse and Mental Health Services Administration (2003). “Nonmedical Use of Prescription-Type Drugs Among Youths and Young Adults.” The NHSDA Report. Research Triangle Park, N.C.: Research Triangle Institute. [Full Text]

——— (2002a). Emergency Department Trends From the Drug Abuse Warning Network, Final Estimates, 1994–2001. Rockville, Md.: Department of Health and Human Services, Office of Applied Studies. [Full Text]

“Emergency department trends from the Drug Abuse Warning Network, Final estimates, 1995-2002”

——— (2002b). Results From the 2001 National Household Survey on Drug Abuse: Volume I. Summary of National Findings. Rockville, Md.: U.S. Department of Health and Human Services, Office of Applied Studies. [Full Text]

Texas Department of Public Safety (2000). Texas Prescription Program. Austin, Texas: Texas Department of Public Safety.

UK Department of Health (1998). “Security of Prescription Forms.” National Health Service Circular 1998/062. [Full Text]

——— (1997). “Alan Milburn Takes Direct Action Against #100M Prescription Fraud.” Press release, June 19.

U.S. Drug Enforcement Administration, Diversion Control Program (2000a). A Closer Look at State Prescription Monitoring Programs. Washington, D.C.: U.S. Drug Enforcement Administration. [Full Text]

——— (2000b). “A Pharmacist’s Guide to Prescription Fraud.” Informational Brochures 1(1). [Full Text]

——— (1999). “Don’t Be Scammed by a Drug Abuser.” Informational Brochures 1(1). [Full Text]

——— (1998). Prescription Accountability Resource Guide. Washington D.C.: U.S. Drug Enforcement Administration.

U.S. General Accounting Office (2002). Prescription Drugs: State Monitoring Programs Provide Useful Tool to Reduce Diversion. Washington, D.C.: U.S. General Accounting Office. [Full Text]

——— (1992). Prescription Drug Monitoring: States Can Readily Identify Illegal Sales and Use of Controlled Substances. Washington, D.C.: U.S. General Accounting Office. [Full Text]

Wesson, D. and D. Smith (1990). “Prescription Drug Abuse.” Western Journal of Medicine 152(5):613–616. [Full Text]

Wick, J. (1995). “Outsmarting Prescription Fraud.” Pharmacy Times 61 (April):33, 35–36.

Wilford, B. (1990). “Abuse of Prescription Drugs.” Addiction Medicine 152 (May):609–612.

Zickler, P. (2001). “NIDA Scientific Panel Reports on Prescription Drug Misuse and Abuse.” Research News, NIDA Notes 16(3) (August). [Full Text]